{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:41:06Z","timestamp":1791009666569,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.lungcan.2008.03.035","type":"journal-article","created":{"date-parts":[[2008,5,20]],"date-time":"2008-05-20T09:01:06Z","timestamp":1211274066000},"page":"321-325","source":"Crossref","is-referenced-by-count":35,"title":["Absence of gene mutations in KIT-positive thymic epithelial tumors"],"prefix":"10.1016","volume":"62","author":[{"given":"Masanori","family":"Tsuchida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Umezu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohiko","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terumoto","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Hosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaaki","family":"Eimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ich","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2008.03.035_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-2000-9868","article-title":"Thymic carcinoma\u2014analysis of nineteen clinicopathological studies","volume":"48","author":"Chung","year":"2000","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.lungcan.2008.03.035_bib2","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1002\/j.1460-2075.1987.tb02655.x","article-title":"Human-proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand","volume":"6","author":"Yarden","year":"1987","journal-title":"EMBO J"},{"key":"10.1016\/j.lungcan.2008.03.035_bib3","first-page":"1259","article-title":"Cloning and structural analysis of the human c-kit gene","volume":"7","author":"Vandenbark","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2008.03.035_bib4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0046-8177(98)90066-1","article-title":"Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders","volume":"29","author":"Arber","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.lungcan.2008.03.035_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain of function mutation of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.lungcan.2008.03.035_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/10428199709114167","article-title":"c-kit point mutation in patients with myeloproliferative disorders","volume":"25","author":"Kimura","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.lungcan.2008.03.035_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00428-003-0883-2","article-title":"Sequence analysis and high-throughput immunohistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarrays","volume":"443","author":"Pache","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1016\/j.lungcan.2008.03.035_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0002-9440(10)63120-3","article-title":"KIT mutations are common in testicular seminomas","volume":"164","author":"Kemmer","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lungcan.2008.03.035_bib9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00432-004-0545-z","article-title":"Tyrosine kinase receptor expression in thymomas","volume":"130","author":"Henley","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.03.035_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1378\/chest.128.1.140","article-title":"Immunohistochemical KIT (CD117) expression in thymic epithelial tumors","volume":"128","author":"Nakagawa","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2008.03.035_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/path.1514","article-title":"KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas","volume":"202","author":"Pan","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.lungcan.2008.03.035_bib12","first-page":"4297","article-title":"Effect of c-kit mutations on prognosis of gastrointestinal stromal tumors","volume":"59","author":"Taniguchi","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2008.03.035_bib13","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","article-title":"Thymic carcinoma with overexpression of mutated KIT and the response to Imatinib","volume":"350","author":"Strobel","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.lungcan.2008.03.035_bib14","series-title":"Pathology and genetics of tumors of the lung, pleura, thymus and heart World Health Organization classification of tumors.","year":"2004"},{"key":"10.1016\/j.lungcan.2008.03.035_bib15","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2008.03.035_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1440-1827.2007.02081.x","article-title":"Comparative study using rabbit-derived polyclonal, mouse-derived monoclonal, and rabbit-derived monoclonal antibodies for KIT immunostaining in GIST and other tumors","volume":"57","author":"Saito","year":"2007","journal-title":"Pathol Int"},{"key":"10.1016\/j.lungcan.2008.03.035_bib17","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1093\/nar\/21.16.3637","article-title":"\u2018Cold SSCP\u2019: a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses","volume":"21","author":"Hongyo","year":"1993","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.lungcan.2008.03.035_bib18","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1038\/sj.bjc.6601819","article-title":"Late resistance to Imatinib therapy in a metastatic gastrointestinal stromal tumor is associated with a second KIT mutation","volume":"90","author":"Wakai","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2008.03.035_bib19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1368-5031.2006.00742.x","article-title":"Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis","volume":"60","author":"Yaren","year":"2006","journal-title":"J Clin Prac"},{"key":"10.1016\/j.lungcan.2008.03.035_bib20","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","article-title":"Kinase mutations and Imatinib response in patients with metastatic gastrointestinal stromal tumor","volume":"21","author":"Heinrich","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.03.035_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canlet.2006.07.003","article-title":"Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas","volume":"248","author":"Meister","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.lungcan.2008.03.035_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1470-2045(07)70141-9","article-title":"Response of thymoma to cetuximab","volume":"8","author":"Farina","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lungcan.2008.03.035_bib23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2741\/2098","article-title":"Cetuximab is an active treatment of metastatic and chemorefractory thymoma","volume":"12","author":"Palmieri","year":"2007","journal-title":"Front Biosci"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950020800192X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950020800192X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T14:44:28Z","timestamp":1557585868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016950020800192X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S016950020800192X"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2008.03.035","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}